glycopeptide resistance gene cluster vanP

Accession ARO:3007187
CARD Short NamevanP_cluster
DefinitionThis cluster confers resistance to both vancomycin and teicoplanin by allowing restructuring of peptidoglycan precursors to end in D-Ala-D-Lac. Resistance is acquired after multiple treatments with sub-minimum inhibitory concentrations of vancomycin. Gene orientation: vanHPXRS.
AMR Gene Familyglycopeptide resistance gene cluster
Drug Classglycopeptide antibiotic
Resistance Mechanismantibiotic target alteration
Classification8 ontology terms | Show
Parent Term(s)3 ontology terms | Show
+ confers_resistance_to_antibiotic vancomycin [Antibiotic]
+ confers_resistance_to_antibiotic teicoplanin [Antibiotic]
+ glycopeptide resistance gene cluster [AMR Gene Family]
Sub-Term(s)
5 ontology terms | Show
Publications

Xavier BB, et al. 2021. Euro Surveill 26(36): Novel vancomycin resistance gene cluster in Enterococcus faecium ST1486, Belgium, June 2021. (PMID 34505571)

Resistomes

Prevalence of glycopeptide resistance gene cluster vanP among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 413 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).

Prevalence: gene cluster meta-model

SpeciesNCBI ChromosomeNCBI PlasmidNCBI WGSNCBI GI
No prevalence data


Detection Models

Model Name: glycopeptide resistance gene cluster vanP

Model Description: This cluster confers resistance to both vancomycin and teicoplanin by allowing restructuring of peptidoglycan precursors to end in D-Ala-D-Lac. Resistance is acquired after multiple treatments with sub-minimum inhibitory concentrations of vancomycin. Gene orientation: vanHPXRS.

Regulatory: vanR gene in vanP clustervanS gene in vanP cluster

Core: vanH gene in vanP clustervanPvanX gene in vanP cluster